ZEALAND PHARMA A/S DK 1/ DK0060257814 /
6/6/2024 8:01:48 AM | Chg. +0.50 | Volume | Bid12:50:21 PM | Ask12:50:21 PM | High | Low |
---|---|---|---|---|---|---|
82.60EUR | +0.61% | 0 Turnover: 0.00 |
86.10Bid Size: 400 | 86.55Ask Size: 400 | 82.60 | 82.60 |
GlobeNewswire
12:29 PM
Zealand Pharma announces that Boehringer Ingelheim will present positive results from Phase 2 trial ...
GlobeNewswire
5/31
Zealand Pharma announces positive CHMP opinion for dasiglucagon for treatment of severe hypoglycemia...
GlobeNewswire
5/29
Zealand Pharma to participate in upcoming healthcare investor conferences in June 2024
GlobeNewswire
5/23
Zealand Pharma announces topline results from the mechanistic investigator-led DREAM trial with low ...
GlobeNewswire
5/9
Zealand Pharma conference call on May 16 at 2pm CET (8am ET) to present first quarter 2024 financial...
GlobeNewswire
3/20
Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatm...
GlobeNewswire
2/26
Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated ...
GlobeNewswire
2/26
Survodutide Phase II trial shows 83% of adults treated achieved groundbreaking results in liver dise...
GlobeNewswire
2/20
Zealand Pharma conference call on February 27 at 2pm CET (8am ET) to present full year 2023 financia...
GlobeNewswire
1/8
Zealand Pharma announces directed issue and private placement for gross proceeds of DKK 1.45 billion
GlobeNewswire
1/2
Zealand Pharma to participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference on Janua...
GlobeNewswire
12/23/2023
U.S. Food and Drug Administration issues Complete Response Letter for dasiglucagon in congenital hyp...
GlobeNewswire
12/22/2023
Zealand Pharma submits New Drug Application to the US FDA for glepaglutide in short bowel syndrome
GlobeNewswire
12/22/2023
Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire
11/30/2023
Zealand Pharma appoints Enrique Conterno and Elaine Sullivan as board observers
GlobeNewswire
11/9/2023
Zealand Pharma Announces Financial Results for the First Nine Months of 2023